PRESS RELEASE published on 08/08/2024 at 09:00, 2 years 1 month ago First half of 2024: RHÖN-KLINIKUM AG continues good business performance – outlook confirmed RHÖN-KLINIKUM AG reports 6.5% revenue increase and 68.9% profit growth in first half of 2024. Outlook for 2024 remains positive amid global uncertainties Revenue Increase Healthcare Sector Outlook 2024 Profit Growth RHÖN-KLINIKUM AG
BRIEF published on 05/08/2024 at 09:04, 2 years 4 months ago RHÖN-KLINIKUM AG annonce un bon début d'année 2024 avec des résultats positifs au premier trimestre Perspectives 2024 L'industrie De La Santé Impact Economique RHÖN-KLINIKUM AG Résultats Financiers Du Premier Trimestre
BRIEF published on 05/08/2024 at 09:04, 2 years 4 months ago RHÖN-KLINIKUM AG Reports Strong Start to 2024 with Positive First Quarter Results 2024 Outlook Healthcare Industry Economic Impact RHÖN-KLINIKUM AG Q1 Financial Results
PRESS RELEASE published on 05/08/2024 at 08:59, 2 years 4 months ago RHÖN-KLINIKUM AG starts financial year 2024 with a good first quarter RHÖN-KLINIKUM AG reports a strong start to financial year 2024 with increased revenues and profits in Q1. The outlook for 2024 confirms positive expectations despite regulatory challenges Revenues Financial Year 2024 Outlook RHÖN-KLINIKUM AG Profits
BRIEF published on 03/28/2024 at 09:05, 2 years 5 months ago RHÖN-KLINIKUM AG annonce des résultats financiers positifs pour 2023 Résultats Financiers Durabilité Soins De Santé Performances 2023 RHÖN-KLINIKUM AG
BRIEF published on 03/28/2024 at 09:05, 2 years 5 months ago RHÖN-KLINIKUM AG Announces Positive Financial Results for 2023 Financial Results 2023 Performance Sustainability Healthcare RHÖN-KLINIKUM AG
PRESS RELEASE published on 03/28/2024 at 09:00, 2 years 5 months ago RHÖN-KLINIKUM AG looks back on successful financial year 2023 RHÖN-KLINIKUM AG reports successful financial year 2023 with increased revenues and profits. Strategic focus on core activities, outpatient care, and sustainability. Outlook for 2024 outlined Revenues Sustainability Financial Year 2023 RHÖN-KLINIKUM AG Profits
PRESS RELEASE published on 11/09/2023 at 09:00, 2 years 10 months ago RHÖN-KLINIKUM AG increases consolidated profit and revenues
PRESS RELEASE published on 08/10/2023 at 09:03, 3 years 1 month ago RHÖN-KLINIKUM Aktiengesellschaft: RHÖN-KLINIKUM AG publishes result for first half of 2023 – outlook confirmed
PRESS RELEASE published on 06/07/2023 at 15:10, 3 years 3 months ago RHÖN-KLINIKUM Aktiengesellschaft: Annual General Meeting approves all agenda items
Published on 09/12/2026 at 02:35, 1 day 10 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 14 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 1 day 15 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 20 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 19 hours 28 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 5 hours ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 15 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 15 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 17 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 2 days 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 days 6 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 2 days 17 hours ago Availability of the 2026 Interim Financial Report
